Home › Digestive Diseases › Illinois
Digestive Diseases clinical trials in Illinois
8 studies for Digestive Diseases are looking for participants at sites in Illinois.
Cities in Illinois
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
- The University of Chicago Medicine, Chicago
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Sep 29, 2026 · NCT07197944Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare - Bloomington, Bloomington
- Illinois Cancer Specialists, Chicago
- and 10 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800Product Surveillance Registry
- Chicago
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chicago
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chicago
- 89bio Clinical Study Site, Glenview
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- Northwestern Memorial Hospital, Chicago
Recruiting
Ages 65 to 82 · All sexes · Updated Aug 13, 2026 · NCT05612347A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT06598943Study of Gastric Motility in Eosinophilic Gastritis
- Northwestern University, Chicago
RecruitingObservational study
Ages 18 to 59 · All sexes · Updated Mar 31, 2026 · NCT05229432From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.